BBIO

BRIDGEBIO PHARMA INC

Institutional Ownership · Q4 2025

Filing: Q4 2025

BRIDGEBIO PHARMA INC (BBIO) is held by 422 institutional investors with combined holdings of $13.5B. Major holders include VANGUARD GROUP INC, BlackRock, Inc. (BLK), VIKING GLOBAL INVESTORS L.

💰 Dark Pool Activity 👤 Insider Trades

Institutional Holders

422

Total Value

$13.5B

Ownership %

105.3%

🏦 Top Institutional Holders

BlackRock, Inc. (BLK)

14.5M shares

$1.1B

7.51% ownership

VIKING GLOBAL INVESTORS LP

14.4M shares

$1.1B

7.42% ownership

Kohlberg Kravis Roberts & Co. L.P.

13.3M shares

$1.0B

6.84% ownership

JANUS HENDERSON GROUP PLC (JHG)

11.0M shares

$841.3M

5.67% ownership

📊 Financials

Income statement, balance sheet, and cash flow from SEC filings.

🏦 Browse Funds

See complete portfolios of top hedge funds.

🎯 AI Signals

Find stocks where multiple funds are accumulating.